Lee Pharma Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24230TG1997PLC028095 Incorporated 06 October 1997 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹928.7 Cr
▲ 2.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹7.65 Cr
Registered with MCA
Paid-up capital
₹1.64 Cr
Issued & subscribed
Open charges
₹592.69 Cr
Satisfied ₹518.66 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
1,381
Latest available

About Lee Pharma Limited

Data last updated: 18 March 2026

Lee Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 06 October 1997, the company has been in operation for over 29 years.

Registered with ROC Hyderabad under CIN U24230AP1997PLC028095.

Capital: an authorised share capital of ₹7.65 Cr and a paid-up capital of ₹1.64 Cr. Formerly known as Lee Pharma Private Limited. It is led by directors including Alla Ratna Kumari and Venkata Reddy Alla.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹928.7 Cr, a growth of 2% compared to the previous year.

The company has a workforce of approximately 1,381 employees as per the latest available data.

The company is associated with 1 brand - Lee Pharma. As per MCA filings, the company has open charges of ₹592.69 Cr and satisfied charges of ₹518.66 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website leepharma.com.

Company Details of Lee Pharma Limited
CIN U24230TG1997PLC028095
Registration Number 028095
Incorporation Date 06 October 1997
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    Survey No.257&258/1 Door No.11 – 6/56 C Block Opp.Idpl Factory Moosapet(Village) Balan, Agar(Post), Hyderabad, Telangana, India – 500037
  • Industry
    Pharma, API Manufacturers, Drug Formulation & Development
Company report
Lee Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Lee Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Lee Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Lee Pharma Limited

Lee Pharma Limited has one previous CIN (Corporate Identification Number): U24230AP1997PLC028095. The current CIN is U24230TG1997PLC028095, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24230TG1997PLC028095 Current
U24230AP1997PLC028095 Previous

Associated Brands with Lee Pharma Limited

Lee Pharma Limited operates one associated brand: Lee Pharma. These brands represent Lee Pharma Limited's diversified market presence and brand portfolio.

Brand Description Website
Pharmaceutical company focused on providing APIs, intermediates, and finished dosage forms leepharma.com

Competitors & Alternatives of Lee Pharma Limited

Brands and companies operating in the same space as Lee Pharma Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.

Competitor Description Location Founded
Concord Biotech Concord Biotech APIs and enzymes are manufactured through fermentation by the CDMO. Ahmedabad, India, India 2000
BDR Pharmaceuticals Internationals BDR Pharmaceuticals Internationals APIs and finished products are developed and manufactured. Mumbai, India, India 2003
Almac Group Almac Group Integrated CDMO services for biopharma R&D and manufacturing are offered. Craigavon, United Kingdom, United Kingdom 2001
Indoco Remedies Indoco Remedies APIs manufacturing and formulation services are provided in therapeutic segments. Mumbai, India, India 1947
Pharmaceutics International Pharmaceutics International Pharmaceutical dosage forms are manufactured by this CDMO. Hunt Valley, United States, United States 1994
Aurobindo Pharma Aurobindo Pharma Generic biocatalytic solutions are provided for pharmaceutical applications. Hyderabad, India, India 1986
Seqens Seqens Contract manufacturing services for small molecules and peptides are provided. Ecully, France, France 2003
Asymchem Asymchem APIs and peptides are developed and manufactured by Asymchem. Morrisville, United States, United States 1995
Aptuit Aptuit Contract research and development services for small molecules are offered. Greenwich, United States, United States 2004
Continuus Pharma Continuus Pharma MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development Woburn, United States, United States 2012

Business Activity of Lee Pharma Limited

Lee Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Lee Pharma Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Lee Pharma Limited

Lee Pharma Limited is currently managed by 8 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Alla Ratna Kumari Whole-Time Director 27 Aug 2007 18 Years 11 Months Current
Venkata Reddy Alla Managing Director 06 Oct 1997 28 Years 10 Months Current
Santosh Babu Busani Director 30 Sep 2021 4 Years 10 Months Current
Vijaykumar Raghunandanprasad Agrawal Director 27 Sep 2007 18 Years 10 Months Current
Raghumitra Alla Whole-Time Director 04 May 2006 20 Years 3 Months Current
Dr Gopala Rao Tatineni Director 22 Apr 1999 27 Years 4 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Lee Pharma Limited FY 2025 filings available

Lee Pharma Limited reported revenue of ₹928.7 Cr (up 2.00% YoY) for FY 2025.

Revenue · FY 2025
₹928.7 Cr ▲ 2.00%
Premium access

Ten-year financial statements for Lee Pharma Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Lee Pharma Limited

Open charges
₹592.69 Cr
Satisfied charges
₹518.66 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹460.23 Cr
Others₹98.00 Cr
Hdfc Bank Limited₹21.96 Cr
Axis Bank Limited₹12.50 Cr
Latest charge details
DateLenderAmountStatus
15 May 2025 Others ₹15 Cr Open
29 Mar 2025 Others ₹18 Cr Open
17 May 2024 Axis Bank Limited ₹12.5 Cr Open
19 May 2023 Others ₹30 Cr Open
19 May 2023 Others ₹5 Cr Open

Total charge records: 44 View all charges

Employees and EPFO Compliance at Lee Pharma Limited

View historical data on people associated with Lee Pharma Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Lee Pharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Lee Pharma Limited

Premium access

GST registrations and filing compliance for Lee Pharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Lee Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Lee Pharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Lee Pharma Limited

Premium access

MSME payment history for Lee Pharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Lee Pharma Limited

Premium access

Corporate group structure for Lee Pharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Lee Pharma Limited

Premium access

MCA filings and documents for Lee Pharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Lee Pharma Limited

Activity
30 Sep 2025
Lee Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
15 May 2025
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101099379 was registered on 15 May 2025.
Activity
31 Mar 2025
Lee Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
29 Mar 2025
A charge with Others amounted to Rs. 18.00 Cr with Charge ID 101082310 was registered on 29 Mar 2025.
Charges
22 Jan 2025
A charge registered on 02 Jan 2024 via Charge ID 100889110 with Others was fully satisfied on 22 Jan 2025.
Charges
09 Dec 2024
A charge with Sbicap Trustee Company Limited of Rs. 460.23 Cr registered on 29 Dec 2022 with Charge ID 100669809 was modified on 09 Dec 2024.

Frequently Asked Questions about Lee Pharma Limited

Lee Pharma Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 06 October 1997 (29+ years old) and is registered under CIN U24230TG1997PLC028095. The company has 1,381 employees.

Lee Pharma Limited reported revenue of ₹928.7 Cr for FY 2025 (up 2.00% YoY).

The current directors of Lee Pharma Limited are:

The primary industry of Lee Pharma Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Lee Pharma Limited can be reached at the registered office: Survey No.257&2581 Door No.11 – 656 C Block Opp.Idpl Factory MoosapetVillage Balan, AgarPost, Hyderabad, Telangana, India – 500037, or through the website leepharma.com.

The authorised capital is ₹7.65 Cr, and the paid-up capital is ₹1.64 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available